People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc. | — | Pharmaceuticals | Series C | $75.0M | $2.6B | 2016 |
James P. Tursi, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James P. Tursi, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric L. Trachtenberg | 1 | 4 |
| Andrew I. Koven | 1 | 4 |
| Mark A. Glickman | 1 | 3 |
| Adrian Adams | 1 | 2 |
| Scott J. Charles | 1 | 2 |
| Kenneth B. Lee Jr. | 1 | 2 |
| Arthur S. Kirsch | 1 | 2 |
| Seth A. Rudnick, M.D. | 1 | 2 |
| Neal F Fowler | 1 | 2 |
| Jason M Aryeh | 1 | 2 |
| Rob F. Harris | 1 | 1 |
| Jennifer L. Armstrong | 1 | 1 |
| F. Martin B. Thrasher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.